Opportunity ID: 331582

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-FD-21-019
Funding Opportunity Title: Dermal Physiologically-based Pharmacokinetic (PBPK) Models Accounting for the Absorption and Evaporation of Vehicle/Co-solvent following the Application of Generic Dermatological Products (U01)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Consumer Protection
Food and Nutrition
Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards: 2
Assistance Listings: 93.103 — Food and Drug Administration Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Feb 17, 2021
Last Updated Date: Feb 17, 2021
Original Closing Date for Applications: Apr 22, 2021
Current Closing Date for Applications: Apr 22, 2021
Archive Date: May 22, 2021
Estimated Total Program Funding:
Award Ceiling: $500,000
Award Floor: $250,000

Eligibility

Eligible Applicants: City or township governments
Native American tribal governments (Federally recognized)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public housing authorities/Indian housing authorities
Private institutions of higher education
Small businesses
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
State governments
County governments
Public and State controlled institutions of higher education
Special district governments
Independent school districts
Native American tribal organizations (other than Federally recognized tribal governments)
For profit organizations other than small businesses
Additional Information on Eligibility: Higher Education Institutions

Public/State Controlled Institutions of Higher Education
Private Institutions of Higher Education
The following types of Higher Education Institutions are always encouraged to apply for FDA support as Public or Private Institutions of Higher Education:

o Hispanic-serving Institutions

o Historically Black Colleges and Universities (HBCUs)

o Tribally Controlled Colleges and Universities (TCCUs)

o Alaska Native and Native Hawaiian Serving Institutions

o Asian American Native American Pacific Islander Serving Institutions (AANAPISIs)

Nonprofits Other Than Institutions of Higher Education

Nonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education)
Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education)
For-Profit Organizations

Small Businesses
For-Profit Organizations (Other than Small Businesses)
Governments

State Governments
County Governments
City or Township Governments
Special District Governments
Indian/Native American Tribal Governments (Federally Recognized)
Indian/Native American Tribal Governments (Other than Federally Recognized)
U.S. Territory or Possession
Other

Independent School Districts
Public Housing Authorities/Indian Housing Authorities
Native American Tribal Organizations (other than Federally recognized tribal governments)
Faith-based or Community-based Organizations
Regional Organizations
Non-domestic (non-U.S.) Entities (Foreign Institutions)

Additional Information

Agency Name: Food and Drug Administration
Description:

The overall objective of this funding opportunity is to develop an enhanced mechanistic PBPK model for generic dermatological drug products by taking account the absorption and evaporation of vehicle/co-solvent simultaneously and implementing the effect of these two dynamic processes on the permeation of drug molecule through skin. The developed model will be utilized to inform decisions on generic dermatological product development, to enhance the understanding of the effect of metamorphosis of dermatological drug products on skin absorption, and to predict the local and systemic exposure of drug molecule following topical application of dermatological drug products. 

Link to Additional Information: RFA-FD-21-019 – Full Announcement
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Shashi Malhotra

Grants Management Specialist

Phone 2404027592
Email:shashi.malhotra@fda.hhs.gov

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: Shashi Malhotra
Grants Management Specialist
Phone 2404027592
Email: shashi.malhotra@fda.hhs.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
93.103 RFA-FD-21-019 FORMS F PKG00265470 Feb 17, 2021 Apr 22, 2021 View

Package 1

Mandatory forms

331582 RR_SF424_2_0-2.0.pdf

331582 PHS398_CoverPageSupplement_4_0-4.0.pdf

331582 RR_OtherProjectInfo_1_4-1.4.pdf

331582 PerformanceSite_2_0-2.0.pdf

331582 RR_KeyPersonExpanded_2_0-2.0.pdf

331582 RR_Budget_1_4-1.4.pdf

331582 PHS398_ResearchPlan_4_0-4.0.pdf

Optional forms

331582 RR_SubawardBudget30_1_4-1.4.pdf

331582 PHS_AssignmentRequestForm_2_0-2.0.pdf

2025-07-11T06:32:10-05:00

Share This Post, Choose Your Platform!

About the Author: